Skip to content
Disclosery

EXANE DERIVATIVES: BMBL position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on BMBL, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 1 BMBL shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 1 shares
    Change vs previous 13F -1,226 shares

    <0.01% of the 13F portfolio, value $28.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 1,227 shares
    Change vs previous 13F -166 shares

    0.01% of the 13F portfolio, value $35,556.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 1,393 shares
    Change vs previous 13F -211 shares

    0.01% of the 13F portfolio, value $47,165.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 1,604 shares
    Change vs previous 13F -318 shares

    0.02% of the 13F portfolio, value $80,165.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 1,922 shares
    Change vs previous 13F +89 shares

    0.02% of the 13F portfolio, value $100,115.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 1,833 shares
    Change vs previous 13F not available

    0.03% of the 13F portfolio, value $114,337.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).